Coverage &
insurance verification

SUPPORT

KALVIN

A REAL ADBRY PATIENT.
Individual results may vary.

CAMRIE

A REAL ADBRY PATIENT.
Individual results may vary.

KALVIN & CAMRIE

REAL ADBRY PATIENTS.
Individual results may vary.

Explore savings and support options available through the Adbry® Advocate™ Program.

See Full Terms, Conditions, and Eligibility Criteria.

Adbry® Rapid Access™ Program

If you have commercial health insurance, you may be able to receive your first dose of Adbry® (tralokinumab-ldrm) for free within 48 hours.^a,b,c

For more information and to check if you qualify for the Adbry® Rapid Access™ Program, call 844-MY-ADBRY (844-692-3279). Restrictions Apply. See Full Terms, Conditions, and Eligibility Criteria.

Adbry® Bridge Care™ Program

Eligible, commercially insured patients whose insurance does not yet cover Adbry® provides for a maximum of six (6) months of shipment of Product, on a periodic basis, within a twenty-four (24) month consecutive time period commencing on the initial date of dispense for such patient’s lifetime, or until such patient receives insurance coverage approval, whichever occurs earlier.^b,c

For more information and to check if you qualify for the Adbry® Bridge Care™ Program, call 844-MY-ADBRY (844-692-3279). Restrictions Apply. See Full Terms, Conditions, and Eligibility Criteria.

Adbry® Copay Program

If you have commercial health insurance, you may be able to pay as little as $0* copay each time you fill Adbry. You do not need to be enrolled in Adbry® Advocate™ to get the Adbry digital copay card.^b,c

For more information and to check if you qualify for the Adbry® Copay Program, call 844-MY-ADBRY (844-692-3279). See Full Terms, Conditions, and Eligibility Criteria.

Activate Copay Card

Adbry Copay Reimbursement Form

Adbry® Patient Assistance Program

If you have financial need and have limited or no prescription coverage, you may be able to receive Adbry at no cost.^b,d

For more information and to check if you qualify for the Adbry® Patient Assistance Program, call 844-MY-ADBRY (844-692-3279). Restrictions Apply. See Full Terms, Conditions, and Eligibility Criteria.

Need additional cost savings support?

The Adbry® Advocate™ Program may provide insurance verification and, for eligible patients, may even help with affordability.

If you’ve been prescribed Adbry® (tralokinumab-ldrm), talk with your healthcare provider to get enrolled.

IMPORTANT: To complete enrollment, you will be required to sign the Patient Consent Form.

Patient Consent Form

^*

Program has an annual cap. Program may not be combined with any third-party rebate, coupon or offer.

^a

The initial dose of Adbry may be shipped either to your office or to the patient after submission of a completed Enrollment and Prescription Form or annual Healthcare Provider eRx Program Certification Form, as applicable, and Patient Authorization. A Case Manager must coordinate shipment to a patient, which may extend delivery time. Patients who have been initiated on therapy with samples are not eligible for Rapid Access™ Product.

^b

Additional terms, conditions and eligibility rules apply. Enrollment in Adbry® Advocate™ is not required to obtain copay support. For all other patient support programs, enrollment in Adbry® Advocate™ is required. Patient or healthcare provider may not seek reimbursement for the benefit received from any party. LEO Pharma reserves the right to rescind, revoke or amend the Program and discontinue support at any time without notice.

^c

Patient is not eligible for the Program if enrolled in any federally or state funded health care program, including but not limited to Medicare (including Medicare Part D), Medicaid, VA, DOD, TRICARE or CHIP.

^d

Income eligibility requirements apply. Patient may be required to submit documentation of income and insurance coverage status.

Keep learning about Adbry:

Frequently asked questions

Get Adbry answers

Adbry information

Sign up

What is Adbry?

Learn about this biologic

INDICATION

What is ADBRY?

ADBRY® (tralokinumab-ldrm) injection is a prescription medicine used to treat people 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. ADBRY can be used with or without topical corticosteroids.
It is not known if ADBRY is safe and effective in children under 12 years of age.

Do not use ADBRY if you are allergic to tralokinumab or to any of its ingredients.

Please see full Prescribing Information, including Patient Information and Instructions for Use.

IMPORTANT SAFETY INFORMATION AND INDICATION

IMPORTANT SAFETY INFORMATION

What should I discuss with my healthcare provider before starting ADBRY?

Tell your healthcare provider about all your medical conditions, including if you:

have eye problems.
have a parasitic (helminth) infection.
are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with ADBRY.
are pregnant or plan to become pregnant. It is not known whether ADBRY will harm your unborn baby. There is a pregnancy exposure registry for women who use ADBRY during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. You or your healthcare provider can get information and enroll you in this registry by calling 1-877-311-8972 or visiting https://mothertobaby.org/ongoing-study/adbry-tralokinumab/.
are breastfeeding or plan to breastfeed. It is not known whether ADBRY passes into your breast milk and if it can harm your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use ADBRY?

See the detailed “Instructions for Use” that comes with ADBRY for information on how to prepare and inject ADBRY and how to properly store and throw away (dispose of) used ADBRY prefilled syringes and autoinjectors.
Use ADBRY exactly as prescribed by your healthcare provider.
Your healthcare provider will tell you how much ADBRY to inject and when to inject it.
ADBRY comes as a single-dose prefilled syringe with needle guard or as an autoinjector.
ADBRY is given as an injection under the skin (subcutaneous injection).
If your healthcare provider decides that you or a caregiver can give the injections of ADBRY, you or your caregiver should receive training on the right way to prepare and inject ADBRY. Do not try to inject ADBRY until you have been shown the right way by your healthcare provider. In children 12 years of age and older, it is recommended that ADBRY be given by or under supervision of an adult.
If you miss a dose, inject the missed dose as soon as possible, then continue with your next dose at your regular scheduled time.
If you inject too much ADBRY than prescribed, call your healthcare provider or call Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.
Your healthcare provider may prescribe other medicines to use with ADBRY. Use the other prescribed medicines exactly as your healthcare provider tells you to.

What are the possible side effects of ADBRY?

ADBRY can cause serious side effects, including:

Allergic reactions (hypersensitivity), including a severe reaction known as anaphylaxis. Stop using ADBRY and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:
- breathing problems
- itching
- skin rash
- swelling of the face, mouth, and tongue
- fainting, dizziness, feeling lightheaded (low blood pressure)
- hives

Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision.

The most common side effects of ADBRY include:

Upper respiratory tract infections
Eye and eyelid inflammation, including redness, swelling, and itching
Injection site reactions
High count of a certain white blood cell (eosinophilia)

These are not all the possible side effects of ADBRY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read more Collapse